Development and biological evaluation of a new nanotheranostic for tuberculosis.
Helal-Neto E, Rocha Pinto S, Portilho FL, da Costa MD, Pereira JX, Nigro F, Ricci-Junior E, Candéa ALP, das Graças Muller de Oliveira Henriques M, Santos-Oliveira R.
Helal-Neto E, et al. Among authors: nigro f.
Drug Deliv Transl Res. 2019 Feb;9(1):97-105. doi: 10.1007/s13346-018-0577-6.
Drug Deliv Transl Res. 2019.
PMID: 30178280